Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using current evidence in selecting antiepileptic drugs for use during pregnancy.

Literature DB >> 16059433

Using current evidence in selecting antiepileptic drugs for use during pregnancy.

Abstract

Children born to mothers taking antiepileptic drugs (AEDs) are at increased risk for findings of fetal anticonvulsant syndrome. Accepted treatment paradigms to minimize fetal risks include use of AED monotherapy and folic acid supplementation. However, as data are acquired from several ongoing pregnancy registries, differential risks among the various AED monotherapy regimens are being defined, further improving fetal outcomes.

Entities: Chemical Species

Year: 2005 PMID： 16059433 PMCID： PMC1176305 DOI： 10.1111/j.1535-7597.2005.05201.x

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

55 in total

1. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents.

Authors: S Koch; K Titze; R B Zimmermann; M Schröder; U Lehmkuhl; H Rauh
Journal: Epilepsia Date: 1999-09 Impact factor: 5.864

2. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age.

Authors: D Vanoverloop; R R Schnell; E A Harvey; L B Holmes
Journal: Neurotoxicol Teratol Date: 1992 Sep-Oct Impact factor: 3.763

3. Evaluation of selected characteristics of pregnancy drug registries.

Authors: M A Honein; L J Paulozzi; J D Cragan; A Correa
Journal: Teratology Date: 1999-12

4. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.

Authors: D Lindhout; H Meinardi; J W Meijer; H Nau
Journal: Neurology Date: 1992-04 Impact factor: 9.910

5. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.

Authors: J G Omtzigt; F J Los; D E Grobbee; L Pijpers; M G Jahoda; H Brandenburg; P A Stewart; H L Gaillard; E S Sachs; J W Wladimiroff
Journal: Neurology Date: 1992-04 Impact factor: 9.910

6. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors:
Journal: Lancet Date: 1991-07-20 Impact factor: 79.321

9. Oxidative stress is increased in women with epilepsy: Is it a potential mechanism of anti-epileptic drug-induced teratogenesis?

Authors: Damayanthi Deepa; Narayani Jayakumari; Sanjeev V Thomas
Journal: Ann Indian Acad Neurol Date: 2012-10 Impact factor: 1.383

9 in total

Using current evidence in selecting antiepileptic drugs for use during pregnancy.

1. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents.

2. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age.

3. Evaluation of selected characteristics of pregnancy drug registries.

4. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.

5. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.

6. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Review 7. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy.

Review 8. Management issues for women with epilepsy: a review of the literature.

9. Normal intelligence in children with prenatal exposure to carbamazepine.

10. Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy.

Review 1. Management of focal-onset seizures: an update on drug treatment.

2. Valproate poses risk to unborn child.

Review 3. Hippocampal GABAergic Inhibitory Interneurons.

4. Metabolome-wide association study of anti-epileptic drug treatment during pregnancy.

Review 5. Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?

6. Lamotrigine in breast milk and nursing infants: determination of exposure.

7. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Review 8. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.

9. Oxidative stress is increased in women with epilepsy: Is it a potential mechanism of anti-epileptic drug-induced teratogenesis?